Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle
- 1 September 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 293 (3) , E843-E848
- https://doi.org/10.1152/ajpendo.00301.2007
Abstract
Smoking causes multiple organ dysfunction. The effect of smoking on skeletal muscle protein metabolism is unknown. We hypothesized that the rate of skeletal muscle protein synthesis is depressed in smokers compared with non-smokers. We studied eight smokers (≥20 cigarettes/day for ≥20 years) and eight non-smokers matched for sex (4 men and 4 women per group), age (65 ± 3 and 63 ± 3 yr, respectively; means ± SEM) and body mass index (25.9 ± 0.9 and 25.1 ± 1.2 kg/m2, respectively). Each subject underwent an intravenous infusion of stable isotope-labeled leucine in conjunction with blood and muscle tissue sampling to measure the mixed muscle protein fractional synthesis rate (FSR) and whole body leucine rate of appearance (Ra) in plasma (an index of whole body proteolysis), the expression of genes involved in the regulation of muscle mass (myostatin, a muscle growth inhibitor, and MAFBx and MuRF-1, which encode E3 ubiquitin ligases in the proteasome proteolytic pathway) and that for the inflammatory cytokine TNF-α in muscle, and the concentration of inflammatory markers in plasma (C-reactive protein, TNF-α, interleukin-6) which are associated with muscle wasting in other conditions. There were no differences between nonsmokers and smokers in plasma leucine concentration, leucine rate of appearance, and plasma concentrations of inflammatory markers, or TNF-α mRNA in muscle, but muscle protein FSR was much less (0.037 ± 0.005 vs. 0.059 ± 0.005%/h, respectively, P = 0.004), and myostatin and MAFBx (but not MuRF-1) expression were much greater (by ∼33 and 45%, respectivley, P < 0.05) in the muscle of smokers than of nonsmokers. We conclude that smoking impairs the muscle protein synthesis process and increases the expression of genes associated with impaired muscle maintenance; smoking therefore likely increases the risk of sarcopenia.Keywords
This publication has 53 references indexed in Scilit:
- Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle massJournal of Applied Physiology, 2007
- Sarcopenic obesity and inflammation in the InCHIANTI studyJournal of Applied Physiology, 2007
- Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expressionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- Myofibrillar protein synthesis in myostatin-deficient miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Hypotension inNKCC1null mice: role of the kidneysAmerican Journal of Physiology-Renal Physiology, 2006
- Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failureInternational Journal of Cardiology, 2005
- Sarcopenia in elderly men and womenAmerican Journal of Preventive Medicine, 2003
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Depressed protein synthesis is the dominant characteristic of muscle wasting and cachexiaClinical Physiology and Functional Imaging, 1983
- Changes in protein synthesis in rats in response to endurance trainingLife Sciences, 1977